Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients ...
Globally, about 5.5% of people with diabetes have DME. When the walls of these tiny vessels are damaged, they weaken and may leak fluid or blood. When fluid gets into the retina’s center part ...
The doctor highlighted a link between increased urination and sudden weight loss as potential early indicators of diabetes, ...
The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and ...
Patients with diabetic retinopathy need special care while pregnant, according to a speaker at Retina 2025. Irena Tsui, MD, said hormonal, metabolic and vascular changes during pregnancy can lead to ...
The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...
( MENAFN - Mid-East Info) The Retina clinic London will showcase cutting-edge innovations in the diagnosis, monitoring, and ...
GlobalData on MSN13d
Ocugen doses first subject in Phase I trial of diabetic macular oedema treatmentUS-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback